User: Guest  Login
Title:

Medical indications and considerations for future clinical decision making.

Document type:
Journal Article; Review
Author(s):
Haas, S
Abstract:
There are many well-known drawbacks associated with the currently used antithrombotic agents, warfarin, heparin, and low-molecular-weight heparins (LMWHs). Because heparins can be administered only parenterally, their application is limited. Though warfarin can be administered orally, its unpredictable anticoagulant effect means that it must be regularly monitored. Ximelagatran (Exanta, AstraZeneca) is a novel, oral direct thrombin inhibitor (oral DTI) that is rapidly converted to its active for...     »
Journal title abbreviation:
Thromb Res
Year:
2003
Journal volume:
109 Suppl
Pages contribution:
S31-7
Language:
eng
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/12818632
Print-ISSN:
0049-3848
TUM Institution:
Institut für Experimentelle Onkologie und Therapieforschung
 BibTeX